98 results
Page 2 of 5
8-K
EX-99.1
05hplexe4f985c zuu
8 May 24
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:07am
ARS
8590vatwp o028z6vj3f
30 Apr 24
Annual report to shareholders
8:52am
8-K
EX-99.1
rr8jzgq8m
4 Mar 24
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
7:05am
8-K
EX-99.1
0f2ze7bb
22 Feb 24
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:15am
8-K
EX-99.1
3mvl9yyd5s wujv5
11 Jan 24
Regulation FD Disclosure
7:05am
8-K
EX-99.1
dkg50um3qwxzm
9 Jan 24
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
4:06pm
8-K
EX-99.2
z8cr7en
12 Dec 23
Regulation FD Disclosure
4:28pm
8-K
EX-99.1
bi37t2 hy
12 Dec 23
Regulation FD Disclosure
4:28pm
8-K
ewy6r5s
12 Dec 23
Entry into a Material Definitive Agreement
7:15am
8-K
EX-99.1
dyyn1kcz151qi4ids
12 Dec 23
Entry into a Material Definitive Agreement
7:15am
8-K
EX-99.1
0j6s4pu9z29sq3o
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
EX-99.1
1fw9zva
1 Nov 23
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
7:18am
8-K
EX-99.1
loob i0mda
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm